Pharmacists' Defence Association
The Pharmacists' Defence Association (PDA) is a not for profit organisation which aims to act upon and support the needs of individual pharmacists and, when necessary, to defend their reputation. In November 2015, the PDA reported having more than 25,000 members[1] in the United Kingdom.
Aims
The stated aims of the PDA are to:
- Support pharmacists in their legal, practice and employment needs
- Represent the individual or collective concerns of pharmacists in the most appropriate manner
- Proactively seek to influence the professional, practice and employment agenda to support members
- Lead and support initiatives designed to improve the knowledge and skills of pharmacists in managing risk and safe practices, so improving patient care
- Work with like-minded organisations to further improve the membership benefits to individual pharmacists
- Provide insurance cover to safeguard and defend the reputation of the individual pharmacist
Campaigns
In 2016, the Association conducted a survey of its members in which pharmacists reported that they were pressurised by Boots UK into conducting unnecessary medicine use reviews, each of which attracts a fee of £28 from the NHS.[2][3] In April 2016, The Guardian stated that the General Pharmaceutical Council was poised to investigate.[4]
References
- ↑ "Pharmacists’ Defence Association Response to Independent Patient Safety Investigations Service (IPSIS) Consultation" (PDF).
- ↑ "Boots accused of 'milking the NHS' for up to £30m a year". The Week. 13 April 2016. Retrieved 15 April 2016.
- ↑ Aditya Chakrabortty (13 April 2016). "Boots staff under pressure to milk the NHS for cash, says pharmacists' union". Guardian newspapers. Retrieved 13 April 2016.
- ↑ Aditya Chakrabortty (17 April 2016). "=Boots could face regulator's investigation after Guardian report". Guardian newspapers. Retrieved 17 April 2016.
External links
See also
This article is issued from Wikipedia - version of the Sunday, April 24, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.